✦ LIBER ✦

Perceived locus of control experienced control, and depression: A trait description of the learned helplessness model of depression

✍ Scribed by Michael R. O'Leary; Dennis M. Donovan; Brian Cysewski; Edmund F. Chaney

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 438 KB
Volume: 33
Category: Article
ISSN: 0021-9762
DOI: 10.1002/1097-4679(197701)33:1+<164::aid-jclp2270330136>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reductions in experienced control and de

Reductions in experienced control and depression in psychiatric inpatients: A test of the learned helplessness model

✍ Ronald G. Evans; W. David Dinning 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 1 views

Perceived contingency of reinforcements,

Perceived contingency of reinforcements, helplessness, locus of control, and academic performance

✍ Kevin J. Kennelly; Suzanne A. Mount 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 1 views

Perceived locus of control as a function

Perceived locus of control as a function of level of depression among alcoholics and nonalcoholics

✍ Dennis M. Donovan; Linda M. Radford; Edmund F. Chaney; Michael R. O'Leary 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

The influence of depressive symptomatolo

The influence of depressive symptomatology on alcoholics' Locus of control: A Methodological note and a correction

✍ Austin L. Errico; Andrea C. King; Oscar A. Parsons 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

Double-Blind Randomized Controlled Pilot

Double-Blind Randomized Controlled Pilot Study of the Efficacy and Tolerability of Pirlindole, a Reversible Inhibitor of Monoamine Oxidase A, and Mianserin, in the Treatment of Depression

✍ J. DE WILDE; C. MERTENS; J. VAN DORPE; J. BRUHWYLER; J. GÉCZY 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

This double-blind randomized pilot study aimed to compare the ecacy and the tolerability of pirlindole (150±225 mg/day), a reversible inhibitor of monoamine oxidase A, and mianserin (60±90 mg/day) in the treatment of major depression. Forty patients were included in the trial (20 pirlindole and 20 m